These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6214367)

  • 21. HL-A antibodies in chimpanzees after specific treatment with human leukocytes and antihuman lymphocyte globulin.
    Johannsen R; Seiler FR
    Transplant Proc; 1972 Mar; 4(1):77-81. PubMed ID: 5011649
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of warm-reactive IgG anti-lymphocyte antibodies in systemic lupus erythematosus. Relative specificity for mitogen-activated T cells and their soluble products.
    Litvin DA; Cohen PL; Winfield JB
    J Immunol; 1983 Jan; 130(1):181-6. PubMed ID: 6600174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of anti-lymphocyte antibody in SLE by double staining method (author's transl)].
    Nakai H; Nakamura T; Okudaira K; Hayakawa T; Tanimoto K; Horiuchi Y; Juji T
    Ryumachi; 1979 Feb; 19(1):31-6. PubMed ID: 85340
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic lupus erythematosus. Some contemporary laboratory aspects.
    Deegan MJ
    Arch Pathol Lab Med; 1980 Aug; 104(8):399-404. PubMed ID: 6967303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus.
    Tanaka S; Matsuyama T; Steinberg AD; Schlossman SF; Morimoto C
    Arthritis Rheum; 1989 Apr; 32(4):398-405. PubMed ID: 2523219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
    Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
    J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of mouse and human monoclonal antibodies cross-reactive with SLE serum antibodies to guanosine.
    Weisbart RH; Chan G; Kacena A; Saxton RE
    J Immunol; 1984 Jun; 132(6):2909-12. PubMed ID: 6725946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular immunological dysfunction in systemic lupus erythematosus.
    Chee YC
    Singapore Med J; 1982 Feb; 23(1):12-8. PubMed ID: 6214005
    [No Abstract]   [Full Text] [Related]  

  • 30. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function.
    Sakane T; Kotani H; Takada S; Murakawa Y; Ueda Y
    J Immunol; 1983 Aug; 131(2):753-61. PubMed ID: 6223093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocytotoxic antibodies in mexican patients with systemic lupus erythematosus and their families relationship of disease activity in the probands to antibody cytotoxicity in their relatives.
    DeHoratius RJ; Alarcón-Segovia D; Messner RP; Fishbein E
    Rev Invest Clin; 1981; 33(2):161-4. PubMed ID: 7291760
    [No Abstract]   [Full Text] [Related]  

  • 32. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
    Merino R; Iwamoto M; Fossati L; Izui S
    J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus.
    Mahowald ML; Dalmasso AP
    Ann Rheum Dis; 1982 Dec; 41(6):593-8. PubMed ID: 7149796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-4Ralpha polymorphism in regulation of IL-4 synthesis by T cells: implication in susceptibility to a subset of murine lupus.
    Shiroiwa W; Tsukamoto K; Ohtsuji M; Lin Q; Ida A; Kodera S; Ohtsuji N; Nakamura K; Tsurui H; Kinoshita K; Nishimura H; Shirai T; Hirose S
    Int Immunol; 2007 Feb; 19(2):175-83. PubMed ID: 17189592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
    Fournel S; Muller S
    Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmunity develops in lupus-prone NZB mice despite normal T cell tolerance.
    Wither J; Vukusic B
    J Immunol; 1998 Nov; 161(9):4555-62. PubMed ID: 9794382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auto-antibodies specific for lymphocyte surface antigens--a review.
    Revillard JP; Rivera S; Robert M
    Comp Immunol Microbiol Infect Dis; 1980; 3(3):261-75. PubMed ID: 7009042
    [No Abstract]   [Full Text] [Related]  

  • 38. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus.
    Monk CR; Spachidou M; Rovis F; Leung E; Botto M; Lechler RI; Garden OA
    Arthritis Rheum; 2005 Apr; 52(4):1180-4. PubMed ID: 15818683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunopathogenesis of autoimmune diseases].
    Yoshiki T
    Hokkaido Igaku Zasshi; 1984 Jul; 59(4):385-9. PubMed ID: 6092248
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.